Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023.

Abdulwadud Nafees, Audrey Gauthier, Antoinette N Davis, Emily F Tran, Christine Abalos, Christa M Girincuti, Samuel Bonti-Ankomah
{"title":"Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023.","authors":"Abdulwadud Nafees, Audrey Gauthier, Antoinette N Davis, Emily F Tran, Christine Abalos, Christa M Girincuti, Samuel Bonti-Ankomah","doi":"10.14745/ccdr.v51i01a03","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Public Health Agency of Canada oversees the <i>Human Pathogens and Toxins Act</i> and <i>Human Pathogens and Toxins Regulations</i>, and monitors human pathogen and toxin incidents in licensed facilities to minimize exposure impact at the individual and population level.</p><p><strong>Objective: </strong>To provide an overview of confirmed laboratory exposure incidents in Canada in 2023.</p><p><strong>Methods: </strong>Confirmed exposure incident reports in 2023 were analyzed using R 4.2.2, Microsoft Excel and SAS.</p><p><strong>Results: </strong>In 2023, 207 incident reports were received, including 63 confirmed exposure incidents that affected 85 individuals. The academic sector accounted for 50.8% (n=32) of the reported confirmed exposure incidents. Microbiology (n=33; 52.4%) was the predominant activity being performed, with the most common occurrence types being sharps-related (n=22; 27.2%) and procedure-related (n=16; 19.8%). Human interaction (n=36; 57.1%) and standard operating procedures (n=24; 38.1%) were the most frequent root causes cited, with corrective actions often directly addressing these causes. Most of the 85 affected individuals were technicians/technologists (n=55; 64.7%) and had a median of 11 years of laboratory experience. Sixty-seven human pathogens and toxins (HPTs) were implicated in the confirmed exposure incidents, with bacteria (n=36; 53.7%) being the most common biological agent type. The median time between the incident and the reporting date was six days.</p><p><strong>Conclusion: </strong>The number of confirmed exposure incidents increased in 2023 compared to 2022. Microbiology was most often the activity being performed at the time of exposure, and occurrence-types, root causes and HPTs implicated in 2023 mirrored those cited in 2022.</p>","PeriodicalId":94304,"journal":{"name":"Canada communicable disease report = Releve des maladies transmissibles au Canada","volume":"51 1","pages":"16-25"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717171/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada communicable disease report = Releve des maladies transmissibles au Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/ccdr.v51i01a03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Public Health Agency of Canada oversees the Human Pathogens and Toxins Act and Human Pathogens and Toxins Regulations, and monitors human pathogen and toxin incidents in licensed facilities to minimize exposure impact at the individual and population level.

Objective: To provide an overview of confirmed laboratory exposure incidents in Canada in 2023.

Methods: Confirmed exposure incident reports in 2023 were analyzed using R 4.2.2, Microsoft Excel and SAS.

Results: In 2023, 207 incident reports were received, including 63 confirmed exposure incidents that affected 85 individuals. The academic sector accounted for 50.8% (n=32) of the reported confirmed exposure incidents. Microbiology (n=33; 52.4%) was the predominant activity being performed, with the most common occurrence types being sharps-related (n=22; 27.2%) and procedure-related (n=16; 19.8%). Human interaction (n=36; 57.1%) and standard operating procedures (n=24; 38.1%) were the most frequent root causes cited, with corrective actions often directly addressing these causes. Most of the 85 affected individuals were technicians/technologists (n=55; 64.7%) and had a median of 11 years of laboratory experience. Sixty-seven human pathogens and toxins (HPTs) were implicated in the confirmed exposure incidents, with bacteria (n=36; 53.7%) being the most common biological agent type. The median time between the incident and the reporting date was six days.

Conclusion: The number of confirmed exposure incidents increased in 2023 compared to 2022. Microbiology was most often the activity being performed at the time of exposure, and occurrence-types, root causes and HPTs implicated in 2023 mirrored those cited in 2022.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人类病原体和毒素的实验室暴露监测,加拿大,2023年。
背景:加拿大公共卫生署负责监督《人类病原体和毒素法》和《人类病原体和毒素条例》,并监测许可设施中的人类病原体和毒素事件,以尽量减少个人和人群一级的接触影响。目的:提供2023年加拿大实验室暴露事件的概况。方法:采用r4.2.2软件、Microsoft Excel软件和SAS软件对2023年确诊的暴露事件报告进行分析。结果:2023年,共收到207起事件报告,其中63起确诊暴露事件,影响85人。在报告确认的暴露事件中,学术部门占50.8% (n=32)。微生物学(n = 33;52.4%)为主要活动,最常见的发生类型为尖锐相关(n=22;27.2%)和手术相关(n=16;19.8%)。人际互动(n=36;57.1%)和标准操作程序(n=24;38.1%)是最常见的根本原因,纠正措施通常直接解决这些原因。85名受影响的个人中,大多数是技术人员/技术人员(n=55;64.7%),平均有11年的实验室经验。67种人类病原体和毒素(HPTs)与确认的暴露事件有关,其中细菌(n=36;53.7%)是最常见的生物制剂类型。从事件发生到报告日期的中间时间是6天。结论:与2022年相比,2023年确诊暴露事件数量有所增加。微生物学是暴露时最常见的活动,2023年涉及的发生类型、根本原因和HPTs与2022年引用的相同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infection. Is there sufficient evidence to inform personal protective equipment choices for healthcare workers caring for patients with viral hemorrhagic fevers? Summary of the National Advisory Committee on Immunization (NACI) Statement-Updated guidance on Imvamune in the context of a routine immunization program. Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023. The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1